Docosanol, also known as Abreva and NAA-422, is a saturated-alcohol antiviral medication used to treat cold sore infections caused by the herpes simplex virus. Docosanol inhibits an event prior to the expression of intermediate early gene products but subsequent to HSV attachment.
Catalog Number | A000652 |
CAS Number | 661-19-8 |
Synonyms | 1-DOCOSANOL; Docosan-1-ol; Behenyl alcohol; Docosanol; 661-19-8; Behenic alcohol |
Molecular Formula | C22H46O |
Purity | ≥95% |
Storage | -20°C |
InChI | 1S/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H3 |
InChIKey | NOPFSRXAKWQILS-UHFFFAOYSA-N |
SMILES | CCCCCCCCCCCCCCCCCCCCCCO |
Reference | 1: You S, Liu Y, Arp Z, Zhao Y, Chaney EJ, Marjanovic M, Boppart SA. 2: [Docosanol (Erazaban), dermal use]. J Pharm Belg. 2011 Jun;(2):53-4. French. <br> 4: Docosanol: new drug. Herpes labialis: barely more effective than an excipient. <br> 6: Leung DT, Sacks SL. Docosanol: a topical antiviral for herpes labialis. Expert <br> 8: Marcelletti JF. Synergistic inhibition of herpesvirus replication by docosanol <br> 10: McKeough MB, Spruance SL. Comparison of new topical treatments for herpes |